Facebook
Twitter
Telegram
Report an ErrorSecond Sight Medical Products Balance Sheet 2011-2024 | EYES
Annual Balance Sheet Second Sight Medical Products
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | -977 K | -8.72 M | -4.47 M | -604 K | -539 K | -239 K | -619 K | 19.1 M | 8.18 M | - | |
Long Term Debt |
19.3 M | - | 902 K | - | - | - | - | - | - | - | 19.2 M | 8.27 M | - |
Long Term Debt Current |
1.38 M | 955 K | 910 K | - | 237 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 2.36 M | - | - | - | - | - | 19.2 M | 8.27 M | - |
Total Current Liabilities |
5.72 M | 6.82 M | 2.09 M | 5.13 M | 6.96 M | 7.6 M | 6.62 M | 5.66 M | 7.98 M | - | - | - | - |
Total Liabilities |
25 M | 6.82 M | 2.99 M | 5.13 M | 9.32 M | 7.6 M | 6.62 M | 5.66 M | 7.98 M | 8.45 M | 21.9 M | 11 M | - |
Deferred Revenue |
- | - | - | 335 K | 335 K | 167 K | 48 K | 189 K | 2.52 M | 4.67 M | 68.9 K | 167 K | - |
Retained Earnings |
-98.4 M | -72.8 M | -58.9 M | -320 M | -305 M | -269 M | -234 M | -206 M | -173 M | -153 M | -117 M | -94.5 M | - |
Total Assets |
45.8 M | 51.1 M | 5.45 M | 4.46 M | 16.6 M | 10.7 M | 14.5 M | 16.8 M | 28.2 M | 43.1 M | 12.7 M | 7.99 M | - |
Cash and Cash Equivalents |
20.7 M | 45.1 M | - | 3.18 M | 11.3 M | 4.47 M | 7.84 M | 539 K | 239 K | 619 K | - | - | - |
Book Value |
20.8 M | 44.3 M | 2.46 M | -672 K | 7.28 M | 3.08 M | 7.88 M | 11.1 M | 20.3 M | 34.6 M | -9.22 M | -3.04 M | - |
Total Shareholders Equity |
20.8 M | 44.3 M | 2.46 M | -672 K | 7.28 M | 3.08 M | 7.88 M | 11.1 M | 20.3 M | 34.6 M | -9.22 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Second Sight Medical Products
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
18.9 M | 19.3 M | 19.7 M | 20.1 M | 349 K | - | 42 K | - | - | 902 K | 102 K | 151 K | 199 K | - | - | - | - | 2.36 M | 2.36 M | 2.36 M | 2.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
25.1 M | 25 M | 27.1 M | 27.2 M | 6.21 M | 6.82 M | 5.66 M | 2.59 M | 2.38 M | 2.99 M | 4.02 M | 3.81 M | 7.14 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 9.32 M | 9.32 M | 9.32 M | 9.32 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 335 K | 167 K | 167 K | 167 K | 167 K | 48 K | 64 K | 147 K | 369 K | 85 K | 85 K | 85 K | 85 K | 322 K | 322 K | 322 K | 322 | 600 K | 600 K | 600 K | 600 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-104 M | -98.4 M | -92.4 M | -85.6 M | -79.1 M | -72.8 M | -65.5 M | -334 M | -331 M | -58.9 M | -327 M | -325 M | -323 M | -320 M | -320 M | -320 M | -320 M | -305 M | -305 M | -305 M | -305 M | -269 M | -269 M | -269 M | -269 M | -234 M | -234 M | -234 M | -234 M | -206 M | -206 M | -206 M | -206 M | -173 M | -173 M | -173 M | -173 K | -153 M | -153 M | -153 M | -153 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
53.8 M | 45.8 M | 53.3 M | 59.6 M | 44.6 M | 51.1 M | 57 M | 65.6 M | 68.5 M | 5.45 M | 73.6 M | 75.9 M | 28.1 M | 4.46 M | 4.46 M | 4.46 M | 4.46 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 28.2 M | 28.2 M | 28.2 M | 28.2 K | 43.1 M | 43.1 M | 43.1 M | 43.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
29.6 M | 20.7 M | 24.8 M | 32.5 M | 38.1 M | 45.1 M | 51.7 M | 56.4 M | 59.6 M | 2.18 M | 1.18 M | 73.8 M | 26.7 M | 3.18 M | 3.18 M | 3.18 M | 3.18 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 4.47 M | 4.47 M | 4.47 M | 4.47 M | 7.84 M | 7.84 M | 7.84 M | 23.9 M | 10.9 M | 539 K | 539 K | 459 | 16 M | 269 K | 407 K | 239 | 619 | 619 K | 619 K | 619 K | 62 K | - | - | - | 145 K | - | - | - | - | - | - | - |
Book Value |
28.7 M | 20.8 M | 26.2 M | 32.4 M | 38.4 M | 44.3 M | 51.4 M | 63.1 M | 66.2 M | 2.46 M | 69.6 M | 72.1 M | 21 M | -672 K | -672 K | -672 K | -672 K | 7.28 M | 7.28 M | 7.28 M | 7.28 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 14.5 M | 14.5 M | 14.5 M | 14.5 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 28.2 M | 28.2 M | 28.2 M | 28.2 K | 43.1 M | 43.1 M | 43.1 M | 43.1 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
28.7 M | 20.8 M | 26.2 M | 32.4 M | 38.4 M | 44.3 M | 51.4 M | -4.82 M | -1.12 M | 2.46 M | 1.43 M | 1.4 M | 1.6 M | -672 K | -672 K | -672 K | -672 K | 7.28 M | 7.28 M | 7.28 M | 7.28 M | 3.08 M | 3.08 M | 3.08 M | 3.08 M | 7.88 M | 7.88 M | 7.88 M | 7.88 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 20.3 M | 24.5 M | 28.1 M | 20.3 K | 34.6 M | 34.6 M | 34.6 M | 34.6 M | -9.22 M | - | - | - | -3.04 M | - | - | - | - | - | - | - |
All numbers in USD currency